» Articles » PMID: 38750510

Overexpression of Pathogenic Tau in Astrocytes Causes a Reduction in AQP4 and GLT1, an Immunosuppressed Phenotype and Unique Transcriptional Responses to Repetitive Mild TBI Without Appreciable Changes in Tauopathy

Abstract

Epidemiological studies have unveiled a robust link between exposure to repetitive mild traumatic brain injury (r-mTBI) and elevated susceptibility to develop neurodegenerative disorders, notably chronic traumatic encephalopathy (CTE). The pathogenic lesion in CTE cases is characterized by the accumulation of hyperphosphorylated tau in neurons around small cerebral blood vessels which can be accompanied by astrocytes that contain phosphorylated tau, the latter termed tau astrogliopathy. However, the contribution of tau astrogliopathy to the pathobiology and functional consequences of r-mTBI/CTE or whether it is merely a consequence of aging remains unclear. We addressed these pivotal questions by utilizing a mouse model harboring tau-bearing astrocytes, GFAP mice, subjected to our r-mTBI paradigm. Despite the fact that r-mTBI did not exacerbate tau astrogliopathy or general tauopathy, it increased phosphorylated tau in the area underneath the impact site. Additionally, gene ontology analysis of tau-bearing astrocytes following r-mTBI revealed profound alterations in key biological processes including immunological and mitochondrial bioenergetics. Moreover, gene array analysis of microdissected astrocytes accrued from stage IV CTE human brains revealed an immunosuppressed astroglial phenotype similar to tau-bearing astrocytes in the GFAP model. Additionally, hippocampal reduction of proteins involved in water transport (AQP4) and glutamate homeostasis (GLT1) was found in the mouse model of tau astrogliopathy. Collectively, these findings reveal the importance of understanding tau astrogliopathy and its role in astroglial pathobiology under normal circumstances and following r-mTBI. The identified mechanisms using this GFAP model may suggest targets for therapeutic interventions in r-mTBI pathogenesis in the context of CTE.

Citing Articles

Repetitive Low-Level Blast Exposure Alters Circulating Myeloperoxidase, Matrix Metalloproteinases, and Neurovascular Endothelial Molecules in Experienced Military Breachers.

Rhind S, Shiu M, Tenn C, Nakashima A, Jetly R, Sajja V Int J Mol Sci. 2025; 26(5).

PMID: 40076437 PMC: 11898641. DOI: 10.3390/ijms26051808.

References
1.
Di Re J, Wadsworth P, Laezza F . Intracellular Fibroblast Growth Factor 14: Emerging Risk Factor for Brain Disorders. Front Cell Neurosci. 2017; 11:103. PMC: 5396478. DOI: 10.3389/fncel.2017.00103. View

2.
Ginsberg S, Malek-Ahmadi M, Alldred M, Chen Y, Chen K, Chao M . Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology. Neurobiol Dis. 2019; 132:104540. PMC: 6834890. DOI: 10.1016/j.nbd.2019.104540. View

3.
Skucas V, Mathews I, Yang J, Cheng Q, Treister A, Duffy A . Impairment of select forms of spatial memory and neurotrophin-dependent synaptic plasticity by deletion of glial aquaporin-4. J Neurosci. 2011; 31(17):6392-7. PMC: 3107562. DOI: 10.1523/JNEUROSCI.6249-10.2011. View

4.
Brenner M, Messing A . Regulation of GFAP Expression. ASN Neuro. 2021; 13:1759091420981206. PMC: 7897836. DOI: 10.1177/1759091420981206. View

5.
He B, Perez S, Lee S, Ginsberg S, Malek-Ahmadi M, Mufson E . Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability. J Comp Neurol. 2020; 528(16):2748-2766. PMC: 7492791. DOI: 10.1002/cne.24929. View